{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:57:55Z","timestamp":1785859075488,"version":"3.56.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1097\/01.shk.0000180619.06317.2c","type":"journal-article","created":{"date-parts":[[2005,9,30]],"date-time":"2005-09-30T04:01:17Z","timestamp":1128052877000},"page":"348-356","source":"Crossref","is-referenced-by-count":74,"title":["CHEMICALLY MODIFIED TETRACYCLINE PREVENTS THE DEVELOPMENT OF SEPTIC SHOCK AND ACUTE RESPIRATORY DISTRESS SYNDROME IN A CLINICALLY APPLICABLE PORCINE MODEL"],"prefix":"10.1097","volume":"24","author":[{"given":"Jay","family":"Steinberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Halter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Carney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne","family":"Golub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210213","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000.","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"R2-9-20210213","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated cost of care.","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"R3-9-20210213","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJM199901213400307","article-title":"Treating patients with severe sepsis.","volume":"340","author":"Wheeler","year":"1999","journal-title":"N Engl J Med"},{"key":"R4-9-20210213","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/01.CCM.0000063475.65751.1D","article-title":"ARDSnet. Incidence of acute lung injury in the United States.","volume":"31","author":"Gross","year":"2003","journal-title":"Crit Care Med"},{"key":"R5-9-20210213","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1097\/01.CCM.0000057843.47705.E8","article-title":"Neutrophils and acute lung injury.","volume":"31","author":"Abraham","year":"2003","journal-title":"Crit Care Med"},{"key":"R6-9-20210213","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1165\/ajrcmb.20.6.3482","article-title":"Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury. Evidence for alveolar macrophage as source of proteinases.","volume":"20","author":"Gibbs","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R7-9-20210213","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1097\/01.CCM.0000057842.90746.1E","article-title":"Proteases and lung injury.","volume":"31","author":"Moraes","year":"2003","journal-title":"Crit Care Med"},{"key":"R8-9-20210213","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1164\/ajrccm.164.5.2103040","article-title":"Leukocyte elastase. Physiological functions and role in acute lung injury.","volume":"164","author":"Lee","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-9-20210213","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/jsre.2001.6180","article-title":"Metalloproteinase inhibition prevents acute respiratory distress syndrome.","volume":"99","author":"Carney","year":"2001","journal-title":"J Surg Res"},{"key":"R10-9-20210213","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00003246-199707000-00001","article-title":"Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment.","volume":"25","author":"Zeni","year":"1997","journal-title":"Crit Care Med"},{"key":"R11-9-20210213","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/01.CIR.100.4.400","article-title":"Matrix metalloproteinase inhibitor prevents acute lung injury following cardiopulmonary bypass.","volume":"100","author":"Carney","year":"1999","journal-title":"Circulation"},{"key":"R12-9-20210213","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-4804(03)00089-1","article-title":"Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats.","volume":"111","author":"Steinberg","year":"2003","journal-title":"J Surg Res"},{"key":"R13-9-20210213","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/01.shk.0000148053.66645.2e","article-title":"The development of acute respiratory distress syndrome after gut ischemia\/reperfusion injury followed by fecal peritonitis in pigs: a clinically relevant model.","volume":"23","author":"Steinberg","year":"2005","journal-title":"Shock"},{"key":"R14-9-20210213","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/0929867013373525","article-title":"The lipophilicity, pharmacokinetics and cellular uptake of different chemically-modified tetracyclines (CMTs).","volume":"8","author":"Liu","year":"2001","journal-title":"Curr Med Chem"},{"key":"R15-9-20210213","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.ATV.0000121571.78696.dc","article-title":"Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial dose of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial.","volume":"24","author":"Brown","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R16-9-20210213","first-page":"455","article-title":"Diabetes increases collagenase activity in extracts of rat gingiva and skin.","volume":"17","author":"Ramamurthy","year":"1983","journal-title":"J Periodontal Res"},{"key":"R17-9-20210213","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/00003246-199612000-00021","article-title":"Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis.","volume":"24","author":"Piper","year":"1996","journal-title":"Crit Care Med"},{"key":"R18-9-20210213","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/jama.1993.03500170051033","article-title":"A controlled trial of HA-1A in a canine model of gram-negative septic shock.","volume":"269","author":"Quezado","year":"1993","journal-title":"J Am Med Assoc"},{"key":"R19-9-20210213","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1073\/pnas.82.6.1790","article-title":": Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies.","volume":"82","author":"Teng","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-9-20210213","first-page":"1097","article-title":"Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin.","volume":"266","author":"Ziegler","year":"1991","journal-title":"N Engl J Med"},{"key":"R21-9-20210213","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trials coordination.","volume":"149","author":"Bernard","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-9-20210213","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1164\/ajrccm.152.1.7599855","article-title":"Sepsis trials: intersection of investigation, regulation, funding and practice.","volume":"152","author":"Bernard","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"R23-9-20210213","first-page":"153","article-title":"Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposis sarcoma: a phase I AIDS malignancy consortium study.","volume":"20","author":"Cianfrocca","year":"2002","journal-title":"J Clin Oncol"},{"key":"R24-9-20210213","doi-asserted-by":"crossref","first-page":"L1222","DOI":"10.1152\/ajplung.00141.2003","article-title":"Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis.","volume":"285","author":"Martin","year":"2003","journal-title":"Am J Physiol Lung Cell Physiol"},{"key":"R25-9-20210213","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1164\/ajrccm.160.4.9811060","article-title":"Ethanol ingestion increases activation of matrix metalloproteinases in rat lung during endotoxemia.","volume":"160","author":"Lois","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R26-9-20210213","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1164\/ajrccm.155.1.9001287","article-title":"Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome.","volume":"155","author":"Torri","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"R27-9-20210213","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1164\/ajrccm.154.2.8756805","article-title":"Matrix metalloproteinases and TIMP in acute respiratory distress syndrome.","volume":"154","author":"Ricou","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"R28-9-20210213","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/0929867013373570","article-title":"A role for the anti-inflammatory properties of tetracyclines in the prevention of acute lung injury.","volume":"8","author":"Nieman","year":"2001","journal-title":"Curr Med Chem"},{"key":"R29-9-20210213","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/01.CCM.0000048626.02184.F8","article-title":"Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.","volume":"31","author":"Lanchou","year":"2003","journal-title":"Crit Care Med"},{"key":"R30-9-20210213","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/bbrc.1996.1787","article-title":"Chemically modified tetracyclines inhibit inducible nitric oxide synthase expression and nitric oxide production in cultured rat mesangial cells.","volume":"229","author":"Trachtman","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"R31-9-20210213","first-page":"975","article-title":"Functional sites of chemically modified tetracyclines: inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases.","volume":"25","author":"Sorsa","year":"1998","journal-title":"J Rheumatol"},{"key":"R32-9-20210213","first-page":"1807","article-title":"Chemically modified non-antimicrobial tetracyclines inhibit activity of phospholipase A2.","volume":"25","author":"Pruzanski","year":"1998","journal-title":"J Rheumatol"},{"key":"R33-9-20210213","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.4049\/jimmunol.163.6.3459","article-title":"A novel mechanism of action of chemically modified (CMTs): inhibition of COX-2 mediated PGE2 production.","volume":"163","author":"Patel","year":"1999","journal-title":"J Immunol"},{"key":"R34-9-20210213","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/IAI.64.3.825-828.1996","article-title":"Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracyclines: correlation with inhibition of cytokine secretion.","volume":"64","author":"Shapira","year":"1996","journal-title":"Infect Immun"},{"key":"R35-9-20210213","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/AAC.41.1.117","article-title":"Intraperitoneal injection of tetracyclines protects mice form lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood.","volume":"41","author":"Milano","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"R36-9-20210213","first-page":"391","article-title":"Such stuff as dreams are made on: mediator-directed therapy in sepsis.","volume":"2","author":"Marshall","year":"2003","journal-title":"Nat Rev"},{"key":"R37-9-20210213","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/0929867013373516","article-title":"Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3).","volume":"8","author":"Lokeshwar","year":"2001","journal-title":"Curr Med Chem"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.shk.0000180619.06317.2c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:04:58Z","timestamp":1785855898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00024382-200510000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.shk.0000180619.06317.2c","relation":{},"ISSN":["1073-2322"],"issn-type":[{"value":"1073-2322","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}